Skip to main content
Premium Trial:

Request an Annual Quote

Speed Dating, BIO-Style

Fortune's David Ewing Duncan asks whether a "marriage between pharma and biotech will create more drugs." Pharmaceutical companies, he notes, "are struggling to replenish research development pipelines," whereas biotech firms "have the best ideas for new drugs but are constantly short of cash." But as of the Biotechnology Industry Organization meeting in Chicago last week, he says, the two are coming together. "Pharma showed its love at the BIO event by deploying small armies of business development people to hold thousands of speed-dating sessions with biotech hopefuls during the four-day meeting," Duncan writes, adding, "For many deals, the courtship began during meetings at the big biotech financial meeting held every January in San Francisco by JP Morgan." While it's too soon to tell whether these marriages will last, Duncan says he expects that these new relationships "will increase the odds that more innovative drugs will emerge."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.